DeepMed Research

Shanghai Mental Health Center (Shanghai Psychological Consulting and Training Center)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Repetitive Transcranial Magnetic Stimulation for the Treatment of Negative Symptoms in Schizophrenia Patients.

Not Applicable

Conditions: Schizophrenia

Interventions: Device: Repetitive Transcranial Magnetic Stimulation

First Posted Date: 2016-07-22

Last Posted Date: 2018-02-26

Lead Sponsor: Shanghai Mental Health Center

Target Recruit Count: 60

Registration Number: NCT02842034

Locations: 🇨🇳
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China

Repetitive Transcranial Magnetic Stimulation for the Treatment of the Tardive Dyskinesia.

Not Applicable

Conditions: Tardive Dyskinesia

Interventions: Device: Repetitive Transcranial Magnetic Stimulation

First Posted Date: 2016-07-21

Last Posted Date: 2018-02-26

Lead Sponsor: Shanghai Mental Health Center

Target Recruit Count: 60

Registration Number: NCT02840760

Locations: 🇨🇳
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China

Transcranial Direct Current Stimulation (tDCS) as a Treatment for Cognitive Deficits in Schizophrenic

Not Applicable

Completed

Conditions: Schizophrenia

Interventions: Device: tDCS
Device: Sham tDCS

First Posted Date: 2016-04-22

Last Posted Date: 2019-01-17

Lead Sponsor: Shanghai Mental Health Center

Target Recruit Count: 49

Registration Number: NCT02748083

Locations: 🇨🇳
Shanghai Mental Health Center, Shanghai, Shanghai, China

Magnetic Seizure Therapy for Schizophrenia

Not Applicable

Terminated

Conditions: Schizophrenia

Interventions: Device: Magpro X100 + Option
Device: ThymatronSystem Ⅳ Electroconvulsive System
Other: treatment as usual (TAU)

First Posted Date: 2016-04-21

Last Posted Date: 2022-05-06

Lead Sponsor: Shanghai Mental Health Center

Target Recruit Count: 79

Registration Number: NCT02746965

Locations: 🇨🇳
Shanghai Mental Health Center, Shanghai, Shanghai, China

The Study of the Pathogenesis and Cognitive Behavioral Group Therapy in Obsessive-Compulsive Disorder

Not Applicable

Completed

Conditions: Obsessive-Compulsive Disorder

Interventions: Behavioral: cognitive behavioral group therapy
Drug: sertraline, fluvoxamine
Other: cognitive behavioral group therapy and drug therapy

First Posted Date: 2016-04-14

Last Posted Date: 2020-01-07

Lead Sponsor: Shanghai Mental Health Center

Target Recruit Count: 142

Registration Number: NCT02739061

Locations: 🇨🇳
Clinical psychiatrist, Shanghai, Shanghai, China

Naltrexone and Bupropion Combination on Obese,Smoking Patients With Schizophrenia

Phase 4

Completed

Conditions: Obese
Cigarette-smoking
Schizophrenia

Interventions: Drug: Placebo Naltrexone
Drug: Naltrexone
Drug: Placebo Bupropion
Drug: Bupropion

First Posted Date: 2016-04-13

Last Posted Date: 2021-10-22

Lead Sponsor: Shanghai Mental Health Center

Target Recruit Count: 22

Registration Number: NCT02736474

Novel Intervention for Amphetamine-type Stimulants Addiction

Not Applicable

Completed

Conditions: Amphetamine Addiction

Interventions: Radiation: repetitive transcranial magnetic stimulation (rTMS)
Radiation: sham repetitive transcranial magnetic stimulation (rTMS)

First Posted Date: 2016-03-21

Last Posted Date: 2019-12-03

Lead Sponsor: Shanghai Mental Health Center

Target Recruit Count: 60

Registration Number: NCT02713815

Locations: 🇨🇳
Shanghai Gaojing Rehabilitation Center, Shanghai, Shanghai, China

An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia

Recruiting

Conditions: Schizophrenia

First Posted Date: 2015-12-29

Last Posted Date: 2021-09-14

Lead Sponsor: Shanghai Mental Health Center

Target Recruit Count: 3000

Registration Number: NCT02640911

Locations: 🇨🇳
Shanghai Mental Health Center, Shanghai, Shanghai, China

The Influence of Omega-3 Fatty Acid on the Violence of Schizophrenia Patient and the Possible Mechanism

Not Applicable

Conditions: Schizophrenia

Interventions: Biological: placebo
Biological: omega-3 fatty acid
Device: positron emission tomography (PET)

First Posted Date: 2015-09-17

Last Posted Date: 2015-09-17

Lead Sponsor: Shanghai Mental Health Center

Target Recruit Count: 100

Registration Number: NCT02552758

Locations: 🇨🇳
Shanghai Mental Health Center, Shanghai, Shanghai, China

Comparison of Yuxintine With Placebo in Treatment of MDD

Phase 2

Conditions: Major Depressive Disorder (MDD)

Interventions: Drug: Yuxintine

First Posted Date: 2015-03-23

Last Posted Date: 2015-03-24

Lead Sponsor: Shanghai Mental Health Center

Target Recruit Count: 160

Registration Number: NCT02395263

Locations: 🇨🇳
the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China
🇨🇳
Affiliated Hospital of Guiyang Medical College, Guiyang, Guizhou, China
🇨🇳
Beijing HuiLongGuan Hospital, Beijing, Beijing, China

and more 7 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy